During the past decade, Burke Pharmaceutical Research conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 30 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 15 clinical trials were completed. i.e. 136.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Burke Pharmaceutical Research" #1 sponsor was "Galderma R&D" with 10 trials, followed by "LEO Pharma" with 7 trials sponsored, "Peplin" with 6 trials sponsored, "Pfizer" with 5 trials sponsored and "Bristol-Myers Squibb" with 5 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Burke Pharmaceutical Research" #1 collaborator was "GlaxoSmithKline" with 2 trials as a collaborator, "Athenex, Inc." with 1 trials as a collaborator, "Dermira, Inc." with 1 trials as a collaborator, "Hexal AG" with 1 trials as a collaborator and "Innovaderm Research" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Burke Pharmaceutical Research" are "Atopic Dermatitis" (10 trials), "Psoriasis" (10 trials), "Actinic Keratosis" (7 trials), "Acne Vulgaris" (6 trials) and "Psoriasis Vulgaris" (5 trials). Many other conditions were trialed in "Burke Pharmaceutical Research" in a lesser frequency.

Most popular intervention types in "Burke Pharmaceutical Research" are "Drug" (64 trials), "Other" (9 trials), "Biological" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Vehicle" (4 trials), "Vehicle Gel" (3 trials), "Vehicle gel" (3 trials) and "Apremilast" (2 trials). Other intervention names were less common.

The vast majority of trials in "Burke Pharmaceutical Research" are 66 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Burke Pharmaceutical Research". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 60 completed trials in Burke Pharmaceutical Research, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Burke Pharmaceutical Research, 4 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".